Aug 24 (Reuters) - Teva Pharmaceutical Industries Ltd
* Teva confirms PTAB’s decisions on two patents in IPR challenge to Copaxone 40 mg
* Teva plans to appeal to United States Court of appeals for Federal Circuit Source text for Eikon: Further company coverage:
Our Standards: The Thomson Reuters Trust Principles.